English
Back
Open Account

海王英特龍暴漲,旗下產品入肺炎新診療方案

海王英特龍公告稱,附屬利巴韋林產品被納入試行第五版新冠病毒肺炎診療方案,今日股價高開高走,現暴漲181.9%,報0.86港元,暫成交5281.73萬港元。
海王英特龍公告稱,附屬利巴韋林產品被納入試行第五版新冠病毒肺炎診療方案,今日股價高開高走,現暴漲181.9%,報0.86港元,暫成交5281.73萬港元。
Views
2677
Posts
20
Join topic
Latest
Hot
    Unlock Pro Investors’ Money-Making Secrets
    Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives
    Unlock it Now
    Related stocks
    No Data